Advanced Health Intelligence Ltd
AHI · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.05 | -0.01 | 0.03 |
| FCF Yield | 0.34% | -18.82% | -6.84% | -26.01% |
| EV / EBITDA | 4.23 | -3.93 | -6.48 | -4.90 |
| Quality | ||||
| ROIC | -74.46% | -1,139.54% | -143.65% | -40.72% |
| Gross Margin | 0.00% | -1,116.46% | -3,003.14% | -334.88% |
| Cash Conversion Ratio | 0.01 | 0.62 | 0.34 | 1.12 |
| Growth | ||||
| Revenue 3-Year CAGR | 36.81% | 20.22% | -20.71% | -34.41% |
| Free Cash Flow Growth | 101.11% | -57.19% | 30.26% | 31.64% |
| Safety | ||||
| Net Debt / EBITDA | 0.52 | -0.44 | 0.04 | -0.40 |
| Interest Coverage | -10.79 | -26.89 | -6.55 | -39.18 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,921.19 | 3.82 | 148.52 | 224.12 |